期刊文献+

P2X7受体在癫痫患者中的表达水平及临床意义 被引量:2

Expression Level and Clinical Significance of P2X7 Receptor in Patients with Epilepsy
下载PDF
导出
摘要 目的观察P2X7受体(P2X7R)在癫痫患者中的表达情况,探讨其在癫痫发病、发展过程中的作用及临床意义。方法选取2014年3月—2015年12月行手术治疗的癫痫96例作为观察组,同时选择同期行神经外科减压或清创患者14例作为对照组。观察2组脑组织中P2X7R mRNA和蛋白、白介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)表达水平。结果 P2X7R在正常脑组织和癫痫患者脑组织中均有表达。观察组P2X7R mRNA和蛋白、IL-1β和TNF-α表达水平均高于对照组(P<0.05)。结论 P2X7R可能参与了癫痫的发生与发展,为药物治疗癫痫提供了新的靶点,检测P2X7R表达水平可为癫痫的预后判断提供一定的依据。 Objective To observe expression level of P2X7 receptor (P2X7R) in patients with epilepsy and to analyze its role and clinical significance in pathogenesis and development of epilepsy. Methods A total of 96 patients with epilepsy undergoing surgeries during March 2014 and December 2015 were selected as observation group, and other 14 patients with decompression or debridement in neurosurgery department at the same period were selected as control group. P2XTR mRNA and protein, interleukin-1β (IL-1β) and tumor necrosis faetor-α (TNF-α) expression levels in cerebral tissues were observed in two groups. Results P2X7 receptors were expressed in both normal and epileptic cere- bral tissues. Compared with those in control group, P2X7R mRNA and protein, IL-1β and TNF-α expression levels were significantly increased in observation group (P 〈 0.05). Conclusion P2X7 receptors may be involved in pathogenesis and development of epilepsy, and provide a new target for epilepsy medication. Detection of P2X7 receptor level can provide a certain basis for judging prognosis of epilepsy.
出处 《解放军医药杂志》 CAS 2017年第7期44-46,共3页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
基金 陕西省自然科学基金项目(2013JM4012)
关键词 癫痫 受体 嘌呤能P2X7 白介素-1Β 肿瘤坏死因子-Α Epilepsy Receptors, purinergic P2X7 Interleukin-1β Tumor necrosis factor-α
  • 相关文献

参考文献4

二级参考文献59

  • 1李润洁,杨颖.36例脑瘫合并癫痫的临床发作类型与脑电图分析[J].中国康复理论与实践,2006,12(2):111-112. 被引量:12
  • 2Engel J Jr. A Proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ilea task force on classification and terminology [ J ]. Epilep- sia, 2001,42(6) :796-803.
  • 3Carlsson M, Olsson I, Hagberg G, et al. Behaviour in children with cerebral palsy with and without epilepsy [ J ]. Dev Med Child Neurol, 2008,50(10) :784-789.
  • 4Jaseja H. Cerebral palsy: Interictal epileptiform dischar- ges and cognitive impairment[ J]. Clin Neurol N eurosurg, 2007,109 ( 7 ) :549-552.
  • 5Zelnik N, Konopnicki M, Bennett Back O, et al. The Risk factors for epilepsy in children with cerebral palsy [ J ]. Eur J Paedia Neur, 2010,14 ( 1 ) :67-72.
  • 6Rahman M M, Akhter S, Karim B A. Karimco Epilepsy in children with Cerebral palsy[ J]. J Med J, 2004,13 (2) :219-223.
  • 7Jaseha H. Treatment of interictal epileptiform discharges in cerebral palsy patients without clinical epilepsy: hope for a better out in prognosis[J]. Clin Neurol N eurosurg, 2007,109 ( 3 ) :221-224.
  • 8Sliwa A, Plucinska G, Bednarczyk J, et al. Post-treat- ment with rapamycindoes not prevent epileptogenesis in the amygdala stimulationmodel of temporal lobe epilepsy [ J ]. Neurosci Lett, 2012,509 ( 2 ) : 105-109.
  • 9Quintero J E, Pomerleau F, Huettl P, et al. Methodology for Rapid measures of glutamate release in rat brain slices using Ceramic-based microelectrode arrays: basic charac- terization and drug pharmacology [ J ]. Brain Res, 2011, 140 (10) : 1121-1129.
  • 10Loughman A,Bowden SC,D'Souza W. Cognitive functioning in idi-opathic generalized epilepsies: A systematic review and meta-analy-sis [ J]. Neurosci Biobehav Rev,2014,43:20-34. DOI: 10.1016/j.neubiorev.2014.02.012.

共引文献17

同被引文献25

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部